TapewireFind a company

person · Reporting owner

Gonzalez Patricia Paola

Disclosed activity across 1 company

Tapewire entity
14497
SEC CIK
0001879701

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ABBOTT LABORATORIESABT · Entity 2314DirectorSeptember 30, 2026October 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ABBOTT LABORATORIES

Report date September 30, 2026 · Filed October 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Equivalent UnitsSEC Table II · derivative / convertible securityDirect6,331 Reported balance After 2026-09-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-09-30 · Grant · Acquired 333 · Balance 6,331

F1: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Filing footnotes · ownership attribution and instrument terms

F1: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2026 Filed Oct 3, 2026 00:11 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 333 $98.83 $32,910.39
Disclosure

SEC source: 0001104659-26-113287 · tm2626917-4_4seq1.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,331

Underlying: Common Shares · 333 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2026 Filed Jul 1, 2026 21:40 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 363 $90.74 $32,938.62
Disclosure

SEC source: 0001879701-26-000008 · form4-07012026_090745.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,963

Underlying: Common Shares · 363 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
April 24, 2026 Filed Apr 28, 2026 22:27 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 2,286 $0.00 $0.00
Disclosure

SEC source: 0001879701-26-000006 · form4-04282026_100407.xml · nonDerivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,205

F1 · shares: Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
March 31, 2026 Filed Apr 2, 2026 21:15 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 321 $102.67 $32,957.07
Disclosure

SEC source: 0001879701-26-000004 · form4-04022026_090438.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,558

Underlying: Common Shares · 321 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 23:15 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 263 $125.29 $32,951.27
Disclosure

SEC source: 0001879701-26-000002 · form4-01052026_110137.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,208

Underlying: Common Shares · 263 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 20:42 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 246 $133.94 $32,949.24
Disclosure

SEC source: 0001879701-25-000007 · form4-10022025_081013.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,922

Underlying: Common Shares · 246 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2025 Filed Jul 1, 2025 21:13 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 242 $136.01 $32,914.42
Disclosure

SEC source: 0001415889-25-018730 · form4-07012025_090745.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,655

Underlying: Common Shares · 242 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
April 25, 2025 Filed Apr 29, 2025 21:30 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 1,635 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-011520 · form4-04292025_090456.xml · nonDerivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,919

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
March 31, 2025 Filed Apr 2, 2025 21:18 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 248 $132.65 $32,897.20
Disclosure

SEC source: 0001415889-25-009731 · form4-04022025_090428.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,393

Underlying: Common Shares · 248 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
December 31, 2024 Filed Jan 3, 2025 22:07 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 291 $113.11 $32,915.01
Disclosure

SEC source: 0001415889-25-000550 · form4-01032025_100122.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,125

Underlying: Common Shares · 291 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2024 Filed Oct 1, 2024 21:33 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 289 $114.01 $32,948.89
Disclosure

SEC source: 0001415889-24-024238 · form4-10012024_091038.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,815

Underlying: Common Shares · 289 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2024 Filed Jul 2, 2024 20:26 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 317 $103.91 $32,939.47
Disclosure

SEC source: 0001415889-24-018894 · form4-07022024_080707.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,509

Underlying: Common Shares · 317 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
April 26, 2024 Filed Apr 30, 2024 21:48 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 1,866 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-011791 · form4-04302024_090432.xml · nonDerivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,284

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
March 31, 2024 Filed Apr 2, 2024 22:40 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 290 $113.66 $32,961.40
Disclosure

SEC source: 0001415889-24-009861 · form4-04022024_100413.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,174

Underlying: Common Shares · 290 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
December 31, 2023 Filed Jan 3, 2024 22:30 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 299 $110.07 $32,910.93
Disclosure

SEC source: 0001415889-24-000361 · form4-01032024_100135.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,870

Underlying: Common Shares · 299 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2023 Filed Oct 3, 2023 22:46 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 340 $96.85 $32,929.00
Disclosure

SEC source: 0001415889-23-013948 · form4-10032023_101019.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,557

Underlying: Common Shares · 340 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 15:56 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 302 $109.02 $32,924.04
Disclosure

SEC source: 0001104659-23-077920 · tm2320556-3_4seq1.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,206

Underlying: Common Shares · 302 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
April 28, 2023 Filed May 2, 2023 23:51 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 1,816 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-007129 · form4-05022023_110519.xml · nonDerivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,418

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
March 31, 2023 Filed Apr 4, 2023 23:27 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 325 $101.26 $32,909.50
Disclosure

SEC source: 0001415889-23-006150 · form4-04042023_110420.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,894

Underlying: Common Shares · 325 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
December 31, 2022 Filed Jan 4, 2023 23:13 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 300 $109.79 $32,937.00
Disclosure

SEC source: 0001415889-23-000433 · form4-01042023_110124.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,561

Underlying: Common Shares · 300 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 21:24 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 341 $96.76 $32,995.16
Disclosure

SEC source: 0001415889-22-010263 · form4-10042022_021015.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,254

Underlying: Common Shares · 341 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2022 Filed Jul 1, 2022 20:25 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 303 $108.65 $32,920.95
Disclosure

SEC source: 0001415889-22-007172 · form4-07012022_010740.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 910

Underlying: Common Shares · 303 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
April 29, 2022 Filed May 3, 2022 21:54 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 1,602 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-004548 · form4-05032022_020525.xml · nonDerivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,602

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
March 31, 2022 Filed Apr 1, 2022 21:22 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 278 $118.36 $32,904.08
Disclosure

SEC source: 0001415889-22-003588 · form4-04012022_020421.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 603

Underlying: Common Shares · 278 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 22:23 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 234 $140.74 $32,933.16
Disclosure

SEC source: 0001415889-22-000232 · form4-01042022_020159.xml · derivative · entry 1

Gonzalez Patricia Paola · CIK 0001879701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323

Underlying: Common Shares · 234 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 21:35 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 88 $118.13 $10,395.44
Disclosure

SEC source: 0001415889-21-004712 · form4-10042021_021034.xml · derivative · entry 1

Gonzalez Patricia P. · CIK 0001879701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88

Underlying: Common Shares · 88 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.